First Hawaiian Bank’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,010
| Closed | -$203K | – | 862 |
|
|
2023
Q4 | $203K | Sell |
6,010
-1,090
| -15% | -$36.8K | 0.01% | 787 |
|
|
2023
Q3 | $218K | Hold |
7,100
| – | – | 0.01% | 771 |
|
|
2023
Q2 | $284K | Hold |
7,100
| – | – | 0.01% | 728 |
|
|
2023
Q1 | $290K | Hold |
7,100
| – | – | 0.01% | 729 |
|
|
2022
Q4 | $274K | Sell |
7,100
-601
| -8% | -$23.2K | 0.01% | 724 |
|
|
2022
Q3 | $410K | Sell |
7,701
-782
| -9% | -$41.6K | 0.02% | 578 |
|
|
2022
Q2 | $495K | Buy |
8,483
+8
| +0.1% | +$467 | 0.02% | 549 |
|
|
2022
Q1 | $647K | Sell |
8,475
-1,966
| -19% | -$150K | 0.02% | 517 |
|
|
2021
Q4 | $628K | Sell |
10,441
-420
| -4% | -$25.3K | 0.02% | 543 |
|
|
2021
Q3 | $608K | Hold |
10,861
| – | – | 0.02% | 438 |
|
|
2021
Q2 | $659K | Hold |
10,861
| – | – | 0.03% | 410 |
|
|
2021
Q1 | $761K | Buy |
10,861
+185
| +2% | +$13K | 0.03% | 373 |
|
|
2020
Q4 | $639K | Buy |
10,676
+676
| +7% | +$40.5K | 0.03% | 393 |
|
|
2020
Q3 | $601K | Buy |
10,000
+880
| +10% | +$52.9K | 0.03% | 372 |
|
|
2020
Q2 | $479K | Sell |
9,120
-75
| -0.8% | -$3.94K | 0.03% | 435 |
|
|
2020
Q1 | $308K | Buy |
9,195
+75
| +0.8% | +$2.51K | 0.02% | 524 |
|
|
2019
Q4 | $413K | Hold |
9,120
| – | – | 0.02% | 552 |
|
|
2019
Q3 | $347K | Sell |
9,120
-175
| -2% | -$6.66K | 0.02% | 600 |
|
|
2019
Q2 | $404K | Buy |
+9,295
| New | +$404K | 0.02% | 530 |
|